Adenovirus: the first effective in vivo gene delivery vector
about
Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder.Virotherapy: cancer gene therapy at last?Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells.Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo deliveryLinear correlation between average fluorescence intensity of green fluorescent protein and the multiplicity of infection of recombinant adenovirus.Engineering Permissive Insertion Sites in the Bacteriophage Phi29 DNA-Linked Terminal Protein.Rapid and reliable healing of critical size bone defects with genetically modified sheep muscle.Influence of cell physiological state on gene delivery to T lymphocytes by chimeric adenovirus Ad5F35.Targeting Motor End Plates for Delivery of Adenoviruses: An Approach to Maximize Uptake and Transduction of Spinal Cord Motor Neurons.CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse.In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis.Angiogenic gene therapy for refractory angina.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.The transgenic animal platform for biopharmaceutical production.Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5.Viruses, Artificial Viruses and Virus-Based Structures for Biomedical Applications.Application of conditionally replicating adenoviruses in tumor early diagnosis technology, gene-radiation therapy and chemotherapy.Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested.Persistence of hAQP1 expression in human salivary gland cells following AdhAQP1 transduction is associated with a lack of methylation of hCMV promoter.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.Getting genetic access to natural adenovirus genomes to explore vector diversity.Preferable sites and orientations of transgene inserted in the adenovirus vector genome: The E3 site may be unfavorable for transgene position.Efficient Gene Transduction of Dispersed Islet Cells in Culture Using Fiber-Modified Adenoviral Vectors.Transient Expression of Functional Glucocerebrosidase for Treatment of Gaucher's Disease in the Goat Mammary Gland.Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice.Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.Viral Vectors, Engineered Cells and the CRISPR Revolution.Fiber-modified hexon-chimeric oncolytic adenovirus targeting cancer associated fibroblasts inhibits tumor growth in gastric carcinoma.Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease.Flexible DNA junction assisted efficient construction of stable gene nanoparticles for gene delivery.Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9.One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors.Physiological Perspective on Therapies of Lymphatic Vessels.Seamless assembly of recombinant adenoviral genomes from high-copy plasmids.In vivo methods for acute modulation of gene expression in the central nervous systemWidespread airway distribution and short-term phenotypic correction of cystic fibrosis pigs following aerosol delivery of piggyBac/adenovirus
P2860
Q27335060-FB2C0B58-006C-4F2E-809E-65A0BC54DFFBQ28066228-583D5A73-F6CC-41D8-A15A-8950A6936D0AQ34047674-4283232A-5368-4A7A-8392-A07B48E84C6DQ35399152-541A2292-CAD0-4CFB-8346-494FF2DC1813Q35604286-476A5A81-8701-4D3E-B6C4-E55F8A969BDCQ36174048-27C59794-73A0-4E9E-9C8A-30A36110C8C3Q36223900-50AB0DF8-6765-41D4-B0E7-E21D6A81FEBFQ36681507-7287B187-4290-40B5-89F9-6FE827202913Q37251346-DDEBA010-27F3-4779-9F13-032313DF9DECQ37446641-061AE667-59BF-4240-801B-5573BD57587EQ37631284-5BA07D28-35AD-47CF-B8AD-CD9E48D5DC3DQ37666051-EFA2392D-DF81-4279-94AA-A3A0B494D663Q38637597-AD54C57F-C81A-4900-A92F-90FD1DC52FABQ38703318-E372A0A3-435B-4812-8515-354AAF5CEB79Q38714835-EEB89979-9B39-4301-BB76-AEA8E717DDE7Q38795239-09C7F765-8469-4CE5-A0D5-93007B67AE0CQ38818912-2225DFAE-361D-4ADB-A811-D89D23EB5921Q38828208-F4C83825-6FBD-4D73-BA91-24C4EBD367BFQ38849248-2C7E069B-2A3D-4388-AD3B-95DB42948A2EQ38852678-735A7A46-0918-4E2C-8A5F-571D8C7A05E6Q38937862-938F06FB-8FD6-4C72-94B0-B5F39A756A19Q39437315-C6214BE2-43C2-4F72-8D20-FEE28C0F694CQ40448157-E22E0C2D-9655-4D48-91E0-BB634F7F035FQ40799079-1CA0CAD7-250E-499E-9350-59A4CAF63A4AQ41109224-B279D2CC-38F4-47CC-9F99-187B3D9AD98AQ41249890-63D86657-03A0-44CF-9BD0-2C2746E7B03DQ41699782-13838745-C813-430C-9CD9-E95D1F6F82D1Q45874356-CC5ACB51-BF4D-44ED-BBA1-0FCD0DF0F068Q46633886-116E1849-7AD8-45C8-971C-139CDCCBBEE3Q47649722-ECCBEC9D-A22C-4900-BDE1-3E9E0495DF28Q51599772-91B094F7-F48A-4496-8E6E-E74B6EA2E1E9Q52431082-186F3C8D-EA68-4304-9EAB-43E8394B1CDFQ55365677-23E0AD93-8140-4B99-A2A8-8FFBFDA8E7B9Q55426074-BA81D81F-D3B4-4A79-9892-7B75502DF229Q55513326-95854B9F-20B4-4746-9D97-8EA97819A45AQ57020987-65834D25-E6F1-4937-AE99-98BCEBC6E9BFQ58700020-B1333054-E11B-4CD2-8FE5-9C26F2E77A2E
P2860
Adenovirus: the first effective in vivo gene delivery vector
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adenovirus: the first effective in vivo gene delivery vector
@en
Adenovirus: the first effective in vivo gene delivery vector.
@nl
type
label
Adenovirus: the first effective in vivo gene delivery vector
@en
Adenovirus: the first effective in vivo gene delivery vector.
@nl
prefLabel
Adenovirus: the first effective in vivo gene delivery vector
@en
Adenovirus: the first effective in vivo gene delivery vector.
@nl
P2860
P356
P1433
P1476
Adenovirus: the first effective in vivo gene delivery vector
@en
P2093
Ronald G Crystal
P2860
P356
10.1089/HUM.2013.2527
P577
2014-01-01T00:00:00Z